Boston, MA, United States of America

Mehran Makvandi

This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehran Makvandi. Retrieved from https://idiyas.com/inventor/mehran-makvandi-3cxv0134

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mehran Makvandi: Innovator in Oncology

Introduction

Mehran Makvandi is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of oncology through his innovative work. His expertise and dedication have led to the development of valuable patents that aim to advance cancer treatment.

Latest Patents

Mehran holds a patent for "B7-H3 Miniproteins, Conjugates, and Uses Thereof." This patent represents a crucial step in the development of targeted therapies for cancer, showcasing his commitment to improving patient outcomes.

Career Highlights

Currently, Mehran is associated with Aktis Oncology, Inc., where he continues to work on groundbreaking research and development in oncology. His role at the company allows him to collaborate with other experts in the field and contribute to innovative solutions for cancer treatment.

Collaborations

Mehran has worked alongside talented colleagues such as Brian Scott Goodman and Ved Srivastava. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries in oncology.

Conclusion

Mehran Makvandi's contributions to the field of oncology through his patent and work at Aktis Oncology, Inc. highlight his dedication to advancing cancer treatment. His innovative spirit and collaborative efforts with fellow researchers position him as a key figure in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…